4
Changes in Ownership
PTC THERAPEUTICS, INC. Filed Acc 0001179110-22-000397
Chief Operating Officer sold 775 shares at $38.53 ($29,857)
- Chief Operating Officer acquired 41,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Klein Matthew B. · Chief Operating Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-07 | Sale : show line 1 in the form | −775 | $38.53 | $29,857 | 16,461 | D |
| 2022-01-07 | Grant or award : show line 2 in the form | +21,000 | 37,461 | D | ||
| 2022-01-07 | Grant or award : show line 3 in the form | +20,000 | 57,461 | D | ||
| Open-market sales · 775 sh · avg $38.53 · $29,857 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2022-01-07 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +52,500 | $38.10 | 2032-01-06 | 52,500 | 52,500 | D |
| 2022-01-07 | Grant or award : show line 5 in the form Stock Option (Right to Buy) | +50,000 | $38.10 | 2032-01-06 | 50,000 | 50,000 | D |
Loading xslF345X03/edgar.xml…